Get the SPI Wire

MEDICUS PHARMA LTD.

NASDAQ:MDCX
Annual Meeting

of Shareholders

MEETING DATE

12/02/2026
DEF 14A FILED
10/30/2026
PUBLISHED
10/30/2026 8:16 pm
TIME TO PUBLISH
11/01/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:MDCX · CUSIP 58471K301 · CLASS common shares · CIK 0001997296

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

2
FOR
1
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Approval of Preferred Share Resolution
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states the shares could have preferential voting rights and make obtaining control more difficult or costly.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Approval of Share Split
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states a larger number of outstanding shares may support broader trading and improved liquidity.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approval of Adjournment Proposal
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states adjournment would permit further solicitation if there are insufficient votes for Proposals 1 or 2.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

8f8600c7336b9f1b8cdc35ccb750320d52b1855a00b748f8f73803010f03fbc5

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates